BPA Call 36C24822A0029-36C24826N0634
Award Date 7/10/26
Potential Completion Date 6/30/27
Potential Value $63K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>Veterans Integrated Service Network 8 issued a BPA call to Mdxhealth, Inc., valued at $144,666.36, under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) on July 1, 2023. The call, set aside for total small business, procures prostate cancer testing services. Place of performance is Irvine, California. The ultimate completion date is June 30, 2024. This call represents a de-obligation of estimated FY23 funds from the parent BPA.</p>
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, issued a BPA call to Mdxhealth, Inc. for prostate cancer testing (Prostate Cancer Test—Option Two) with a ceiling value of $66,501.87 and an award date of July 1, 2024. The call was issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Place of performance is Irvine, California. The ultimate completion date is March 6, 2026. The call is set aside as Total Small Business...
- Mdxhealth, Inc. was awarded a $9,578.79 firm fixed price call under a Blanket Purchase Agreement with Veterans Integrated Service Network 17 (VISN 17) on April 3, 2024, for AMA Oncotype Prostate Cancer Testing services. The work will be performed at Mdxhealth's facility in Irvine, California, with an ultimate completion date of April 2, 2025. This call order falls under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), a General Services Administration...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded Mdxhealth, Inc. a $27,657.57 firm fixed-price blanket purchase agreement call for DX Prostate Testing services. The award, issued on April 3, 2025, with an ultimate completion date of April 2, 2026, represents a delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Mdxhealth, a for-profit molecular diagnostic company headquartered in Irvine,...
- This federal contract is for the provision of prostate cancer diagnostic testing services by Mdxhealth, Inc. to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network (VISN) 8. The contract has a period of performance from October 1, 2020 to September 20, 2021, with a completion date of March 31, 2022. It is a firm fixed price delivery order issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule...
- Mdxhealth, Inc. received a $15,964.65 firm fixed price contract award from the Department of Veterans Affairs' Veterans Integrated Service Network 17 on June 5, 2025. This BPA call is for Genomic Prostate Score (GPS) testing services, a molecular diagnostic test designed to assess prostate cancer risk and guide personalized treatment decisions for veterans. The contract carries no set-aside designation and represents a delivery order against Mdxhealth's existing $240,000 blanket purchase...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17) awarded Mdxhealth, Inc. a $15,964.65 firm fixed price contract call under an existing Blanket Purchase Agreement for Genomic Prostate Score (GPS) testing services. This contract call, with an ultimate completion date of June 4, 2027, represents a delivery order against Mdxhealth's $240,000 BPA for MDXHEALTH GPS services established on May 1, 2023 and extending through June 4, 2028. The contract is issued under...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 17 (VISN 17), to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract is for Oncotype DX prostate testing services, with an ultimate completion date of April 30, 2025, and a ceiling value of $213,926.31. The contract is issued under the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a $27,657.57 firm fixed-price Blanket Purchase Agreement (BPA) call to Mdxhealth, Inc. for DX Prostate Testing services. The contract, which was awarded on April 3, 2026 with an ultimate completion date of April 2, 2027, is performed at the awardee's facility in Amarillo, Texas. This BPA call is issued under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal...
- This is a $9,696.96 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract is for DX Prostate Testing services, which will be delivered to the Veterans Integrated Service Network (VISN) 17 over a period ending on January 9, 2027. The contract was awarded on January 10, 2026 and is not set aside....
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70066-36C24822A0029Blanket Purchase Agreement
- 36C24822A0029-36C24826N0634BPA Call
Veterans Integrated Service Network 8 issued a BPA call to Mdxhealth, Inc. on July 10, 2026, for prostate cancer testing services under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), with a ceiling value of $62,667.50 and a completion date of June 30, 2027. The call is set aside for total small business. Work is performed in Irvine, California. The call encompasses Option 4 of a prostate cancer diagnostic testing engagement, leveraging molecular and biomarker analysis capabilities to support personalized screening and treatment strategy development for veterans.
Generated 7/11/26, 10:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.7k | 7/9/26 |